好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Annual Meeting | C180 - Update on the Immunotherapies of Myasthenia Gravis

Wednesday 04/22/26
11:15 AM - 12:15 PM CDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Yuebing Li, MD, PhD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Following this session attendees will describe the effectiveness and the side effects of traditional immunotherapies for myasthenia gravis; recognize the advantages and the disadvantages of newer-generation immunotherapies for myasthenia gravis; employ strategies for incorporating traditional and newer-generation immunotherapies in treating myasthenia gravis in clinical practice.
1.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic
Event Timeline
11:15 AM - 11:16 AM CDT Introduction Introduction
Yuebing Li, MD, PhD, FAAN
11:17 AM - 11:43 AM CDT Speaker Reviewing of Traditional Immunotherapies for Myasthenia Gravis
John A. Morren, MD, FAAN
11:44 AM - 12:10 PM CDT Speaker Reviewing of Newer-generation Immunotherapies for Myasthenia Gravis
Yuebing Li, MD, PhD, FAAN
12:10 PM - 01:10 PM CDT Q&A Questions and Answers
Yuebing Li, MD, PhD, FAAN, John A. Morren, MD, FAAN
Faculty Disclosures
Yuebing Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
John A. Morren, MD, FAAN Dr. Morren has received publishing royalties from a publication relating to health care.